GHK-Cu vs AHK-Cu: A Research Comparison
5 min read · Updated · For research use only
GHK-Cu and AHK-Cu are both copper(II) complexes of short tripeptides that contain histidine. On paper, they look almost interchangeable. They differ by a single amino acid at the start of the chain. That one swap changes the molecule's identity and how it holds copper. It also changes the body of lab research attached to each. This article sets GHK-Cu vs AHK-Cu side by side for lab research only.
How do GHK-Cu and AHK-Cu differ?
GHK-Cu and AHK-Cu differ only in their first amino acid: glycine versus alanine.
GHK-Cu is the copper complex of glycyl-L-histidyl-L-lysine. This tripeptide was first isolated from human plasma in the early 1970s. It was later found in saliva and urine, where its reported level declines with age.
The peptide binds one copper(II) ion per molecule. That bound metal is central to most of the biochemistry in the literature. GHK-Cu is the most fully studied member of the copper peptide family.
AHK-Cu is the copper complex of alanyl-L-histidyl-L-lysine. The only sequence change is at position one. Alanine replaces glycine and adds a small methyl side chain to the first residue.
That small edit makes a distinct compound. It has its own registry numbers and molecular weight. It also has a largely separate research record.
How do they bind copper, and why does the complex matter?
Both peptides grip copper the same way. The central histidine, the starting amine group, and nearby backbone nitrogens form a cage around the copper(II) ion. This cage is called a chelate. It lets a small peptide carry a reactive metal in a defined form, not as a free ion in solution.
That is why the copper complex, not the free peptide, is usually the material of interest. Copper is a cofactor for enzymes involved in several processes:
- Building the extracellular matrix.
- Antioxidant signaling.
- Blood vessel processes.
So the complex is studied as a controlled way to deliver copper to a cell system. Labs working with GHK-Cu routinely run the complex next to plain GHK. This separates effects that need the metal from effects of the peptide itself.
The copper binding is also visible. Both come as blue freeze-dried powders. The blue comes from the copper(II) center itself, not an additive. That makes color a useful check when a shipment arrives.
How do the specifications compare side by side?
- GHK-Cu: formula C14H24CuN6O4, CAS 49557-75-7, PubChem CID 378611. Molecular weight is about 403.92 g/mol for the complex, and about 340.38 g/mol for free GHK. Synonyms: Copper tripeptide-1, Cu-GHK, prezatide copper.
- AHK-Cu: formula C15H26N6O4 free, and C15H24ClCuN6O4 as the monohydrochloride copper complex. CAS 682809-81-0, PubChem CID 7408502. Molecular weight is about 354.41 g/mol free and 451.39 g/mol as the complex. Synonyms: Copper Tripeptide-3, Ala-His-Lys copper.
- Formats: GHK-Cu in 50 mg and 100 mg vials and AHK-Cu in 20 mg and 50 mg vials. Both are freeze-dried and verified to at least 99 percent purity.
- Storage for both: at or below 25 degrees Celsius, sealed, away from heat, light, and moisture. Keep freeze-dried and chilled or frozen for the long term.
Note the salt form when working out strengths. AHK-Cu is listed as a monohydrochloride complex. So vial mass and moles of peptide do not line up one for one with GHK-Cu figures. Scaling by molar amount matters in any direct comparison.
How does their research focus differ?
GHK-Cu research centers on the extracellular matrix, while AHK-Cu research centers on hair follicle and blood vessel models.
The GHK-Cu literature focuses on connective tissue cells and the extracellular matrix. It has been studied for its effect on fibroblasts, the cells that build connective tissue. Topics include:
- Collagen and glycosaminoglycan synthesis.
- Control of matrix metalloproteinases, the enzymes that break down matrix, and their natural inhibitors.
All of these govern matrix turnover in tissue repair models. Wider gene expression studies have linked GHK exposure to changes in large numbers of genes in cultured cells. These span antioxidant response, inflammatory signaling, and remodeling programs. The GHK-Cu mechanism of action overview breaks these steps down further.
AHK-Cu has been studied in a different set of systems. In ex vivo human hair follicle models, it has been studied for follicle lengthening. It has also been studied for growth of dermal papilla cells. Reported links were strongest at very low levels.
It has also been studied for signals that promote new blood vessels, including markers such as VEGF. Fibroblast growth assays are another focus, as covered in the AHK-Cu mechanism of action overview.
There is real overlap. Both appear in comparison studies that isolate sequence-driven differences in copper binding, uptake, and signaling. The shared histidine-centered motif keeps the metal chemistry roughly the same while the first residue changes. That is exactly why they are compared.
How do stability and handling differ?
Copper peptides need more care than plain peptides. The metal center is sensitive to light and prone to oxidation.
- Keep vials sealed and shielded from light.
- Use amber or foil-wrapped containers for working solutions.
- Split into aliquots after reconstitution, so freeze-thaw cycles do not hit the whole stock.
Buffer chemistry needs attention with both. Competing chelators and reducing agents can change the form the copper takes. Then the species a cell sees may no longer be the complex that was weighed out. When a study compares GHK-Cu and AHK-Cu, matching buffers across arms matters as much as matching molar strength.
Standard practice applies to both. Follow institutional procedures and wear suitable protective gear. Dispose of copper waste properly. Log lot numbers and storage history, so a result traces back to a specific batch.
Which copper peptide suits which research question?
Choose GHK-Cu when the question centers on one of these:
- Extracellular matrix turnover.
- Fibroblast collagen and glycosaminoglycan output.
- Control of matrix metalloproteinases.
- Copper-driven gene expression profiles.
Its deep published record also makes it the better reference when benchmarking a new copper-binding compound.
Choose AHK-Cu when the model is based on follicles or dermal papilla cells. It also fits when blood vessel growth markers are the readout. It suits studies of sequence effects within the copper peptide family, too. Its narrower literature limits benchmarking. But it suits probing a less studied variant.
For designs that expose cells to two agents at once, the GHK-Cu and KPV blend pairs GHK-Cu with KPV in one freeze-dried vial. KPV is the Lys-Pro-Val end fragment of alpha-melanocyte-stimulating hormone. Single-compound vials stay cleaner when an effect must be traced to one agent.
How are GHK-Cu and AHK-Cu sourced and documented?
Puritide Research supplies both compounds as high-purity, research-use-only materials. They are sourced and third-party tested, not produced in-house.
Every batch of GHK-Cu and AHK-Cu ships with a third-party-verified certificate of analysis. It covers:
- Purity by HPLC.
- Identity confirmed by mass spectrometry.
- Lot number, test date, and methods used.
Sample certificates are available as PDFs before purchase.
Common research questions
What is the actual difference between GHK-Cu and AHK-Cu?
Both are copper(II) complexes of a tripeptide with a central histidine and a lysine at the end. They differ only at the first residue: glycine in GHK and alanine in AHK. That gives them separate CAS numbers, separate PubChem entries, and different molecular weights. Their research records are also largely separate.
Does the bound copper matter, or could the free peptide be used instead?
Much of the biochemistry reported for GHK-Cu depends on copper. That is why comparison studies run the complex against plain GHK. The free peptide is a valid study arm. But it is a control, not an equivalent.
How should copper peptides be stored between experiments?
Keep the freeze-dried material sealed at or below 25 degrees Celsius, away from heat, light, and moisture. Keep it chilled or frozen for the long term. Split dissolved material into aliquots to limit freeze-thaw cycles. Protect solutions from light, and log any change in the typical blue color.
For research use only. GHK-Cu and AHK-Cu are supplied by Puritide Research strictly as laboratory research materials. They are not approved for human or veterinary use, and nothing above describes any application outside a controlled research setting.
Common questions
What is the difference between GHK-Cu and AHK-Cu?
GHK-Cu and AHK-Cu are copper(II) complexes of tripeptides with a central histidine and an end lysine. They differ only at the first residue, glycine in GHK and alanine in AHK. That gives them separate CAS numbers, different molecular weights, and largely separate research records.
Why is the copper complex studied instead of the free peptide?
The copper complex is studied because much of the biochemistry reported for GHK-Cu depends on the bound copper. The peptide cages the copper(II) ion in a defined form. Labs often run plain GHK alongside the complex as a control to separate copper-driven effects from peptide effects.
How should GHK-Cu and AHK-Cu be stored?
GHK-Cu and AHK-Cu are stored sealed at or below 25 degrees Celsius, away from heat, light, and moisture, and chilled or frozen long term. Dissolved material is split into aliquots, protected from light, and checked for any change in its typical blue color.
Referenced compound
GHK-Cu 50mg →Copper-binding tripeptide (Gly-His-Lys-Cu) studied in ECM remodelling and dermal gene-expression research. Lyophilized.
Related reading
For research use only. Not for human or veterinary use. Content is provided for laboratory research and educational purposes.
